Rocket Pharmaceuticals Inc. (RCKT)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 2 |
| Ownership rank: | 348 |
| % of all portfolios: | 0.021% |
| Hold Price * : | $18.47 |
| History | Portfolio Manager | Activity ▲ | Share change | % change to portfolio | |
| Q3 2024 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 4.85% | 190,360 | 0.07 | |
| ≡ | Torray Funds | Add 9.24% | 6,208 | 0.02 | |
| Q2 2024 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 1.03% | 40,000 | 0.02 | |
| ≡ | Torray Funds | Add 10.31% | 6,283 | 0.02 | |
| Q1 2024 | |||||
| ≡ | Torray Funds | Add 0.13% | 77 | 0.00 | |
| ≡ | Lee Ainslie - Maverick Capital | Reduce 3.61% | 145,756 | 0.08 | |
| Q4 2023 | |||||
| ≡ | Torray Funds | Add 1.13% | 679 | 0.00 | |
| ≡ | Lee Ainslie - Maverick Capital | Reduce 28.35% | 1,595,902 | 0.99 | |
| Q3 2023 | |||||
| ≡ | Torray Funds | Add 10.28% | 5,608 | 0.02 | |
| ≡ | Lee Ainslie - Maverick Capital | Add 28.54% | 1,250,000 | 0.60 | |
| Q2 2023 | |||||
| ≡ | Torray Funds | Add 0.62% | 337 | 0.00 | |
| ≡ | Lee Ainslie - Maverick Capital | Reduce 0.63% | 27,653 | 0.01 | |
| Q1 2023 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 29.80% | 1,011,805 | 0.45 | |
| ≡ | Torray Funds | Reduce 0.17% | 92 | 0.00 | |
| Q4 2022 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 34.10% | 863,452 | 0.41 | |
| ≡ | Torray Funds | Reduce 4.61% | 2,627 | 0.01 | |
| Q3 2022 | |||||
| ≡ | Torray Funds | Reduce 5.83% | 3,524 | 0.01 | |
| Q2 2022 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 18.71% | 399,200 | 0.14 | |
| ≡ | Torray Funds | Add 38.53% | 16,820 | 0.04 | |
| Q1 2022 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 12.57% | 238,200 | 0.07 | |
| ≡ | Torray Funds | Add 19.77% | 7,206 | 0.02 | |
| Q4 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 14.15% | 234,850 | 0.06 | |
| ≡ | Torray Funds | Reduce 3.53% | 1,333 | 0.00 | |
| Q3 2021 | |||||
| ≡ | Torray Funds | Add 1.13% | 422 | 0.00 | |
| ≡ | Lee Ainslie - Maverick Capital | Add 854.71% | 1,486,229 | 0.49 | |
| Q2 2021 | |||||
| ≡ | Torray Funds | Add 28.56% | 8,299 | 0.05 | |
| ≡ | Lee Ainslie - Maverick Capital | Buy | 173,887 | 0.07 | |
| Q1 2021 | |||||
| ≡ | Torray Funds | Reduce 15.68% | 5,403 | 0.04 | |
| Q4 2020 | |||||
| ≡ | Torray Funds | Reduce 29.37% | 14,331 | 0.13 | |
| Q3 2020 | |||||
| ≡ | Torray Funds | Add 0.45% | 218 | 0.00 | |
| Q2 2020 | |||||
| ≡ | Torray Funds | Reduce 13.96% | 7,881 | 0.03 | |
| Q1 2020 | |||||
| ≡ | Torray Funds | Add 87.83% | 26,400 | 0.08 | |
| Q4 2019 | |||||
| ≡ | Torray Funds | Buy | 30,058 | 0.12 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.